OTCMKTS:NICXFNicOx Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NicOx SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.82 0.00 (0.00 %) (As of 07/9/2020 04:00 PM ET) Add Compare Share Today's Range$4.82Now: $4.82▼$4.8250-Day Range$4.23MA: $4.57▼$4.8252-Week Range$4.13Now: $4.82▼$5.91VolumeN/AAverage Volume3 shsMarket Capitalization$161.33 millionP/E RatioN/ADividend YieldN/ABeta0.57 ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Nicox S.A., an ophthalmic company, researches, develops, and markets therapies that target various ophthalmic conditions in France and internationally. The company's product pipeline includes VyzultaTM, an intraocular pressure-lowering treatment; and NCX 470, a nitric oxide (NO)-donating candidate to treat glaucoma, as well as stand-alone NO donors for specific applications in ophthalmic diseases. It also develops ZERVIATE, an eye drop formulation of cetirizine for allergic conjunctivitis; NCX 4280, an ophthalmic solution that targets morning ocular congestion; and NCX 4251, a patented formulation of fluticasone propionate to treat blepharitis. The company has collaborations with Bausch + Lomb, Astra Zeneca, Merck, Pfizer, and Ironwood Pharmaceuticals, Inc., as well as Novaliq GmbH. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for NicOx. Previous Next 1.9 Community Rank Outperform VotesNicOx has received 102 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNicOx has received 169 “underperform” votes. (Add your “underperform” vote.)Community SentimentNicOx has received 62.36% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NicOx and other stocks. Vote “Outperform” if you believe NICXF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NICXF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNicOx does not currently pay a dividend.Dividend GrowthNicOx does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NicOx insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for NicOx are expected to grow in the coming year, from ($0.80) to ($0.67) per share. Previous Next Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.51 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NICXF Previous SymbolNASDAQ:NICXF CUSIPN/A CIKN/A Webwww.nicox.com Phone33-4-97-24-53-00Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees31 Outstanding Shares33,470,000Market Cap$161.33 million Next Earnings DateN/A OptionableNot Optionable OTC:NICXF Rates by TradingView Receive NICXF News and Ratings via Email Sign-up to receive the latest news and ratings for NICXF and its competitors with MarketBeat's FREE daily newsletter. NicOx (OTCMKTS:NICXF) Frequently Asked Questions How has NicOx's stock been impacted by COVID-19 (Coronavirus)? NicOx's stock was trading at $4.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NICXF stock has increased by 10.8% and is now trading at $4.82. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of NicOx? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NicOx in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NicOx. Has NicOx been receiving favorable news coverage? News headlines about NICXF stock have trended somewhat negative this week, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NicOx earned a news impact score of -1.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news about NicOx. Who are some of NicOx's key competitors? Some companies that are related to NicOx include Paypoint (PYPTF), OPHIR ENERGY PL/ADR (OPHRY), ELEMENTIS PLC/ADR (ELMTY), Orocobre (OROCF), TCG BDC (CGBD), Absolute Software (ALSWF), DATATEC Ltd/ADR (DTTLY), SThree (STREF), WIRECARD AG/ADR (WCAGY), Wandisco (WANSF), Amerisur Resources (ASUXF), NEXCF (NEXCF), Capstone Mining (CSFFF), LONMIN PLC/S (LNMIY) and PARKSON RETAIL/ADR (PKSGY). View all competitors. Who are NicOx's key executives? NicOx's management team includes the following people: Mr. Michele Garufi, Co-Founder, Chairman & CEO (Age 65)Ms. Sandrine Gestin, VP of Fin. (Age 52)Dr. Michael V. W. Bergamini, Chief Scientific Advisor (Age 72)Mrs. Emmanuelle Pierry, Sr. Director of Legal AffairsDr. Gavin Spencer, Exec. VP, Chief Bus. Officer & Head of Corp. Devel. (Age 49) What is NicOx's stock symbol? NicOx trades on the OTCMKTS under the ticker symbol "NICXF." How do I buy shares of NicOx? Shares of NICXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is NicOx's stock price today? One share of NICXF stock can currently be purchased for approximately $4.82. How big of a company is NicOx? NicOx has a market capitalization of $161.33 million. NicOx employs 31 workers across the globe. What is NicOx's official website? The official website for NicOx is www.nicox.com. How can I contact NicOx? NicOx's mailing address is Drakkar 2 - Batiment D 2405 route des Dolines - CS 10313 Sophia Antipolis Cedex, Valbonne I0, 06560. The company can be reached via phone at 33-4-97-24-53-00. This page was last updated on 7/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
